Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Long-Term Deferred Tax: 2015-2025

Historic Long-Term Deferred Tax for Mimedx Group (MDXG) over the last 4 years, with Sep 2025 value amounting to $21.6 million.

  • Mimedx Group's Long-Term Deferred Tax fell 29.34% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year decrease of 29.34%. This contributed to the annual value of $28.3 million for FY2024, which is 30.58% down from last year.
  • As of Q3 2025, Mimedx Group's Long-Term Deferred Tax stood at $21.6 million, which was down 20.99% from $27.4 million recorded in Q2 2025.
  • In the past 5 years, Mimedx Group's Long-Term Deferred Tax ranged from a high of $40.8 million in Q4 2023 and a low of $21.6 million during Q3 2025.
  • For the 3-year period, Mimedx Group's Long-Term Deferred Tax averaged around $31.1 million, with its median value being $29.5 million (2024).
  • Data for Mimedx Group's Long-Term Deferred Tax shows a maximum YoY slumped of 30.58% (in 2024) over the last 5 years.
  • Mimedx Group's Long-Term Deferred Tax (Quarterly) stood at $40.8 million in 2023, then plummeted by 30.58% to $28.3 million in 2024, then dropped by 29.34% to $21.6 million in 2025.
  • Its last three reported values are $21.6 million in Q3 2025, $27.4 million for Q2 2025, and $27.7 million during Q1 2025.